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Abstract
Four new bisabolane sesquiterpenes, altaicalarins A–D (1–4) and three known analogues (5–7) were
isolated from the roots and rhizomes of Ligularia altaica. The structures were elucidated by
spectroscopic methods including 2D NMR techniques, and the structure of 1 was confirmed by
single-crystal X-ray diffraction. The isolated compounds were also evaluated for cytotoxic activity
against human lung carcinoma (A-549), human breast adenocarcinoma (MCF-7), epidermoid
carcinoma of the nasopharynx (KB), and vincristine-resistant nasopharyngeal (KBVIN) cell lines,
and 1 was found to show significant cytotoxicity with EC50 values of 3.4, 0.8, 1.0, and 0.9 µg/mL,
respectively.
Ligularia altaica DC. (Asteraceae) is widely distributed in the Altaica mountains of China,
and its roots and rhizomes are used as a folk medicine in the Xinjiang region, China for easing
breathing, stimulating blood flow, reducing inflammation, stopping cough, and eliminating
phlegm.1 In prior investigations, flavonoids, triterpenes, sterols, benzofurans, and
eremophilane sesquiterpenes were reported.2–4 As part of our program to discover anticancer
agents from Chinese herbs, a phytochemical investigation of the roots and rhizomes of this
plant led to the isolation and characterization of four new (1–4) and three known [1β,8-
diangloyloxy-3β,4β,10,11- diepoxybisabol-7(14)-ene (5),5 1β-acetoxy-1β,8-
diangloyloxy-10,11-dihydroxy-3,4- epoxybisabol-7(14)-ene (6),6 and bisabolone (7)7]
bisabolane sesquiterpenes. Herein we report the isolation and structural elucidation of the new
compounds, as well as their in vitro cytotoxicity evaluation of all isolates against human lung
carcinoma (A-549), human breast adenocarcinoma (MCF-7), epidermoid carcinoma of the
nasopharynx (KB), and vincristine-resistant nasopharyngeal (KBVIN) cell lines.
Results and Discussion
An EtOH extract of the roots and rhizomes of L. altaica was suspended in H2O and partitioned
successively with petroleum ether, EtOAc, and n-BuOH. Repeated column chromatography
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of the combined EtOAc and petroleum ether portions on silica gel and RP18 gel, followed by
preparative TLC, yielded four new (1–4) and three known (5–7) bisabolane sesquiterpenes.
Compound 1 was obtained as a colorless solid and its molecular formula was determined as
C22H28O6 with nine degrees of unsaturation by HREIMS (m/z 388.1897). The IR spectrum
showed absorption bands for OH (3423 cm−1), ester carbonyl (1740 cm−1), and double bond
(1694 cm−1) moieties. The 1H and 13C NMR spectra (Table 1 and Table 2) displayed the
characteristic signals of an angeloyloxy group [δH 6.08 (1H, qq, J = 7.0, 1.5 Hz), 1.97 (3H, dq,
J = 7.0, 1.1 Hz), 1.90 (3H, dq, J = 1.5, 1.1 Hz); δC 167.3 (C), 127.9 (C), 138.1 (CH), 15.7
(CH3), 20.6 (CH3)],8 and an acetoxy group [δH 2.30 (3H, s); δC 170.3 (C), 20.7 (CH3)], in
accordance with the significant MS fragment peaks at m/z 288 [M-AngOH]+ and m/z 246 [M-
AngOH-HOAc]+. Apart from these two ester groups, the 13C NMR and DEPT spectra of 1
revealed 15 skeletal carbon signals, including three methyl, two methylene, three methine,
seven quaternary carbons, and the typical carbon signals for a terminal double bond [δC 144.4
(C) and 115.0 (CH2)]. The 1H NMR data of 1 displayed signals accounting for 18 protons: two
hydroxy groups [δH 5.47, 5.58 (broad s)], one aromatic [δH 2.11, 3H, s], two allylic [δH 1.52,
1.65 (each 3H s)] methyls, two methylenes, including one exocyclic methylene [δH 5.09, 5.30
(each 1H, br s)], and three methines, including an oxymethine proton [δH 5.61, dd, J = 7.8, 7.8
Hz], a trisubstituted olefinic proton [δH 5.07, dd, J = 7.4, 1.5 Hz], and an aromatic proton
[δH 6.36 (1H, s)]. HMBC correlations were found between the proton at δH 5.07 (1H, dd) with
carbons at δC 25.7 (C-12) and 17.8 (C-13), the protons at δH 1.65 (3H, s) and 1.52 (3H, s) with
the carbon at δC 119.2 (C-10), and the proton at δH 2.24 (1H, dd) with carbons at δC 119.2
(C-10) and 134.1 (C-11), which proved the presence of a prenyl group (Figure 1). The above
spectroscopic data were in agreement with those reported for an aromatic bisabolane
sesquiterpene with an angeloyloxy group, an acetoxy group, and two hydroxy groups.9
Furthermore, in the HMBC spectrum of 1 (Figure 1), the correlations of the proton at δH 5.61
(1H, d) with carbons at δC 167.3 (OAng, C-1'), 144.4 (C-7), 119.2 (C-10), 115.0 (C-14), and
32.2 (C-9) indicated attachment of the angeloyloxy group to C-8, whereas the correlations of
the proton at δH 6.36 (1H, s) with carbons at δC 129.7 (C-1), 112.3 (C-3), and 146.5 (C-4)
together with the correlations of the methyl protons at δH 2.11 (3H, s) with carbons at δC 152.1
(C-2), 112.3 (C-3), and 146.5 (C-4) indicated that the two hydroxy groups and an acetoxy group
might be located at C-2, C-4, and C-1, respectively. However, the absolute configuration at
C-8 could not be determined. The structure of 1 was further confirmed by X-ray crystallography
(Figure 2). Therefore, 1 was established as 1-acetoxy-2,4-dihydroxy-8-
angeloyloxybisabola-1,3,5,7(14),10(11)- pentaene, named as altaicalarin A.
The HREIMS of 2 gave m/z 330.1825 in accordance with the molecular formula C20H26O4
and eight unsaturation degrees. The IR spectrum showed absorptions for hydroxy (3260
cm−1), ester carbonyl (1703 cm−1), and double bond (1674 cm−1) moieties. Most of the NMR
data of 2 were similar to those of 1 (Table 1 and Table 2), except that signals for an acetoxy
group were absent. 1H NMR signals for a pair of proton doublets [δH 6.63, 6.48 (each 1H, d,
J = 7.8 Hz)] and the HMBC correlations of the proton at δH 5.83 (H-OH) with carbons at δC
124.0 (C-3), 142.9 (C-4), and 140.5 (C-5), and of the proton at δH 9.00 (−OH) with carbons at
C-4 and C-5, indicated that the two hydroxy groups should be located at C-4 and C-5,
respectively (Figure 1). The configuration of 2 was the same as that of 1, because they both
had a positive optical rotation. Thus, 2 was determined as 4,5-dihydroxy-8-
angeloyloxybisabola-1,3,5,7(14),10(11)-pentaene, named as altaicalarin B.
Compound 3, colorless gum, has a molecular formula of C22H30O6 on the basis of HRESIMS
data (m/z 413.1931 [M+Na]+). The 1H and 13C NMR spectra (Table 1 and Table 2) displayed
signals for angeloyloxy and acetoxy groups. The 13C NMR and DEPT spectra revealed 15
additional skeletal carbon signals: three methyl, three methylene, five methine, and four
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quaternary carbons. To accommodate 8 degrees of unsaturation, compound 3 was proposed to
have a monocyclic sesquiterpene skeleton with a terminal double bond [δH 5.12, 5.26 (each
1H, br s); δC 113.0 (CH2) and 147.5 (C)], an epoxy group [δH 3.45 (1H, dd, J = 4.3, 4.3 Hz);
δC 64.5 (CH), 61.4 (C)], a carbonyl group (δC 201.3), an angeloyloxy group, and an acetoxy
group. 1H-1H COSY 2D-NMR data indicated the two main structural sequences, –CH–CH2–
CH–CH– and –CH–CH2–CH–, which can be further connected with other fragments based on
the following HMBC correlations: H-15/C-4; H-2/C-3; H-5/C-4, C-7; H-8/C-7; H-12, H-13/
C-10 (Figure 3). Thus, 3 was determined as a bisabolane sesquiterpene.10
In the HMBC spectrum of 3, correlations of the proton at δH 5.70 (1H, d) with carbons at δC
169.7 (OAc), 201.3 (C-4), and 43.8 (C-6), and of the proton at δH 5.10 (1H, dd) with carbons
at δC 166.8 (OAng, C-1'), 147.5 (C-7), 118.9 (C-10), 113.0 (C-14), and 32.0 (C-9) indicated
that the acetoxy and angeloyloxy groups are attached to C-5 and C-8, respectively. The HMBC
correlations of the proton at δH 3.45 (1H, d) with carbons at δC 31.8 (C-1), 61.4 (C-3), and 43.8
(C-6) indicated that the epoxy group should be assigned at C-2 and C-3. The location of the
carbonyl group at C-4 was established by HMBC correlations of the protons at δH 1.45 (3H,
s) and 5.70 (1H, d) with carbon at δC 201.3 (C-4).
The stereo-structure of 3 was deduced from the 1H NMR coupling constants and the ROESY
spectrum (Figure 3). When H-6 is assumed to be in an α–orientation,11 H-5 should be β-axial
due to a large 3 J5, 6 value (12.9 Hz), and the proton at δH 2.25 should be H-1 and α-oriented
due to a smaller 3 J1, 6 value (8.2 Hz). In the ROESY spectrum, the obvious correlation of H-2
with H-1α and H-15 revealed that the epoxy group should be 2β,3β-oriented. The relative
configuration at C-8 could not be determined from the spectroscopic data. Thus, the structure
of 3 was determined as 5α-acetoxy-8-angeloyloxy-2β,3β-epoxybisabola-7(14),10(11)-dien-4-
one, named as altaicalarin C.
The molecular formula of 4 was determined as C27H36O9 based on the HRESIMS (m/z
527.2250 [M+Na]+). The IR spectrum indicated the presence of ketone (1755 cm−1) and ester
carbonyl groups (1720 cm−1), and a double bond (1647 cm−1). The 1H and 13C NMR spectra
(Table 1 and Table 2) displayed signals for one acetoxy and two angeloyloxy groups. Apart
from the three ester groups, the 1H, 13C NMR, and 1H-1H COSY spectra (Figure 3) of 4
indicated that the basic skeleton of compound 4 was similar to that of 3, except for an epoxy
group [δH 2.76 (1H, t, J = 5.8 Hz); δC 60.8 (CH), 58.3 (C)] at C-10 and C-11 in 4, rather than
a corresponding trisubstituted double bond in 3.
The locations of the two epoxy groups at C-2, C-3 and C-10, C-11 were confirmed by HMBC
correlations of the proton at δH 3.45 (1H, s) with carbons at δC 71.6 (C-1), 61.4 (C-3), and 48.5
(C-6), and of the proton at δH 2.76 (1H, dd) with carbons at δC 72.6 (C-8), 33.5 (C-9), and 24.6
(C-12). The HMBC correlations of the proton at δH 5.70 (1H, d) with carbons at δC 169.4
(OAc), 199.5 (C-4), and 48.5 (C-6), the proton at δH 5.50 (1H, d) with carbons at δC 166.2
(OAng), 65.6 (C-2), 61.4 (C-3), and 72.8 (C-5), and the proton at δH 5.43 (1H, dd) with carbons
at δC 166.0 (OAng), 145.5 (C-7), and 60.8 (C-10), indicated that the acetoxy group is at C-5
and the two angeloyloxy groups are at C-1 and C-8. (Figure 3)
The relative configuration of the stereogenic centers of the cyclohexane ring in 4 was the same
as those in 3, based on the 1H NMR coupling constants (J5, 6 = 11.7, J6, 1 = 7.8 Hz) and the
ROESY correlations between H-1/H-2 and H-2/H-15. The relative configurations at C-8 and
C-10 could not, however, be determined from the spectroscopic data Thus, the structure of 4
was determined as 1β,8-diangeloyloxy-5α-acetoxy-2β,3β;10,11-diepoxybisabola-7(14)-en-4-
one, named as altaicalarin D.
All isolates were evaluated for their in vitro cytotoxicity against human lung carcinoma
(A-549), human breast adenocarcinoma (MCF-7), epidermoid carcinoma of the nasopharynx
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(KB), and vincristine-resistant nasopharyngeal (KBVIN) cell lines according to a described
procedure.12 The results are listed in Table 3. The most potent compound, 1, exhibited
significant cytotoxicity against all four cell lines with EC50 values of 3.4 (A549), 0.8 (MCF-7),
1.0 (KB), and 0.9 (KBVIN) µg/mL. Compound 2, which differs from 1 in the number and
position of the aromatic hydroxy and ester groups, showed only weak cytotoxicity against the
latter three cancer cell lines. Among the compounds without an aromatic ring, 6–7 showed no
activity (EC50 >20 µg/mL) against the cell line panel, 3 showed weak activity against all four
cell lines while 4 and 5 showed weak activity only against KBVIN. Generally, the compounds
with a C-10-C-11 double bond (1–3) showed broader cytotoxicity compared with compounds
with a C-10-C-11 epoxy group (4–5).
Experimental Section
General Experimental Procedures
Melting points were measured on an XT-4 micro-melting point apparatus and are uncorrected.
Optical rotations were recorded on a JASCO P-1020 polarimeter at room temperature. UV
spectra were measured on a Shimadzu UV-260 spectrophotometer in absolute MeOH. IR
spectra were recorded on an Avatar 360 FT-IR ESP spectrometer in CH2Cl2. Mass spectra
were determined on an HP5989A mass spectrometer for EIMS, a Waters Micromass GCT mass
spectrometer for HREIMS, and a Bruker Daltonics APEXШ 7.0 TESLA FTMS mass
spectrometer for HRESIMS. 1H and 13C NMR spectra were recorded on a Bruker DRX-400
spectrometer in CDCl3. Analytical and preparative TLC were run on silica gel plates (GF254,
Yantai Institute of Chemical Technology, Yantai, China). Spots were observed under UV light
and visualized by spraying with 10% H2SO4, followed by heating. Column chromatography
was performed on silica gel (200–300 mesh and 300–400 mesh; Qingdao Marine Chemical
Factory, Qingdao, China) and Lichroprep RP18 gel (40–60 µm, Merck, Darmstadt, Germany).
X-ray crystallographic analysis was carried out on a Bruker Smart Apex CCD diffractometer
with graphite-monochromated Mo Kα radiation (λ= 0.71073 Å). The structure was solved by
direct methods using the program SHELXS. Non-hydrogen atoms were refined anisotropically.
Hydrogen atoms were located by geometry and riding on the related atoms during refinements
with a temperature factor of 1.2 or 1.5 times of the latter’s.
Plant Material
The roots and rhizomes of L. altaica were collected in August 2005 on the Altaica mountains
(altitude 2000 m) in Xinjiang, China. The identity of the plant material was verified by
Professor Ping Yan at Shihezi University and a voucher specimen (WQ-LA-05-2) has been
deposited in the Herbarium of Materia Medica, Department of Pharmacognosy, School of
Pharmacy, Fudan University, Shanghai, People’s Republic of China.
Extraction and Isolation
The dried and powdered materials (5.0 kg) were extracted three times with 95% EtOH at reflux
temperature and filtered. The filtrate was evaporated in vacuo to give a residue (360 g), a portion
of which (350 g) was suspended in H2O (2 L) and partitioned successively with petroleum
ether (3×1.5 L) and EtOAc (3×1.5 L). The combined EtOAc (160 g) and petroleum ether (50
g) extracts were chromatographed on Si gel (200–300 mesh, 2 kg, 10×120 cm) column, eluted
successively with petroleum ether-acetone (50:1, 30:1, 15:1, 9:1, 7:1, 5:1, 3:1, 2:1, 1:1) to yield
fractions 1–6. Subsequently, fractions 1, 2, 3, 5 and 6 were subjected to silica gel CC with
petroleum ether-EtOAc (80:1, 25:1, 15:1, 5:1, 3:1), respectively. Fraction 1 (26 g) yielded 7
(740 mg). Fraction 2 (28 g) gave two fractions 2a and 2b. Fraction 2a (16 g) was applied to
silica gel CC with petroleum ether-EtOAc (30:1) to afford 5 (287 mg), and fraction 2b (6 g)
was chromatographed similarly, followed by CC on RP18 gel with MeOH-H2O (80:20) to give
2 (25 mg). Fraction 3 (27 g) gave two fractions 3a and 3b. Fraction 3b (7 g) was applied to
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silica gel CC with petroleum ether-EtOAc (9:1) to afford 4 (68 mg). Fraction 5 (25 g) gave
two fractions 5a and 5b. Fraction 5a (5 g) was applied to silica gel CC with petroleum ether-
EtOAc (6:1) to give 6 (262 mg), and fraction 5b (6 g) was applied to silica gel CC with
petroleum ether-EtOAc (5:1), followed by prep TLC with petroleum ether-acetone (12:1) to
give 3 (138 mg). Fraction 6 (39 g) afforded 1 (66 mg), after further purification over prep TLC
with CHCl3-acetone (20:1).
1-Acetoxy-2,4-dihydroxy-8-angeloyloxybisabola-1,3,5,7(14),10(11)-pentaene (1)
—colorless blocks (acetone); mp. 122–123°C;  +129 (c 0.3, MeOH); IR υmax (KBr): 3423,
1740, 1694, 1644, 1434, 1239, 1098 cm−1; UV λmax (MeOH) nm (log ε): 284 (sh), 211 (1.36);
For 1H NMR (CDCl3) and 13C NMR (CDCl3) spectroscopic data, see Table 1 and Table 2;
EIMS m/z 388 [M]+ (2.6), 288 [M-AngOH]+ (26.7), 246 [M-AngOH-AcOH]+ (97.0), 231
(60.6), 177 (100), 83 (39.1), 55 (30.3); HREIMS m/z 388.1897 (calcd for C22H28O6, 388.1886);
Crystal data:13 C22H28O6, Mr = 388.44, monoclinic, space group C 2, a = 17.066 (4) Å, b =
6.9212 (15) Å, β = 100.536 (4) °, c = 19.004 (4) Å, V = 2206.9 (8) Å3, Z = 4, Dcalc = 1.169
Mg/m3. The final R value were R1 = 0.0564 and wR2 = 0.1220 for 6925 observed reflections
[I>2σ(I)].
4,5-Dihydroxy-8-angeloyloxybisabola-1,3,5,7(14),10(11)-pentaene (2)—colorless
gum,  +23.3 (c 0.6, MeOH); IR υmax (CH2Cl2): 3260, 2921, 1703, 1674, 1463, 1257, 739
cm−1; UV λmax (MeOH) nm (log ε): 280 (sh), 210 (1.26); For 1H NMR (CDCl3) and 13C NMR
(CDCl3) spectroscopic data, see Table 1 and Table 2; EIMS m/z 330 [M]+ (2.3), 230 [M-
AngOH]+ (33.7), 215 [M-AngOH-Me]+ (42.3), 193 [M-AngOH-H−2×H2O]+ (9.4), 161 (100),
83 (68.8), 55 (87.1); HREIMS m/z 330.1825 (calcd for C20H26O4, 330.1831).
5α-Acetoxy-8-angeloyloxy-2β,3β-epoxybisabola-7(14),10(11)-dien-4-one (3)—
colorless gum,  −26.3 (c 0.5, MeOH); IR υmax (CH2Cl2): 1735, 1646, 1459, 1378, 1142,
736 cm−1; For 1H NMR (CDCl3) and 13C NMR (CDCl3) spectroscopic data, see Table 1 and
Table 2 ; EIMS m/z 331 (2.7), 228 (2.9), 173 (10.1) , 97 (100); HRESIMS: m/z 413.1931 [M
+Na]+ (calcd for C22H30O6Na, 413.1934).
1β,8-Diangeloyloxy-5α-acetoxy-2β,3β;10,11-diepoxybisabola-7(14)-en-4-one (4)
—colorless gum,  +44.4 (c 0.2, MeOH); IR νmax (CH2Cl2): 1757, 1720, 1647, 1457, 1378,
1230, 1148, 1040, 754 cm−1; For 1H NMR (CDCl3) and 13C NMR (CDCl3) spectroscopic data,
see Table 1 and Table 2 ; EIMS m/z 405 [M+H-AngOH]+ (2.7), 263 [M+H-2AngOH-
AcOH]+ (1.2), 219 (4.6), 83 (100); HRESIMS: m/z 527.2250 [M+Na]+ (calcd for
C27H36O9Na, 527.2251).
Growth Inhibition Assay
Drug stock solutions were prepared in DMSO and stored at −70 °C. Upon dilution into culture
medium, the final DMSO concentration was ≤1% DMSO (v/v), a concentration without effect
on cell replication. The human tumor cell line panel consisted of lung carcinoma (A-549),
breast adenocarcinoma (MCF-7), epidermoid carcinoma of the nasopharynx (KB), and
vincristine-resistant nasopharyngeal (KBVIN). Etoposide was used as control. Cell culture and
other procedures were the same as those reported previously.12 The EC50 value is the
concentration that inhibited growth by 50% following two days of continuous exposure.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Key HMBC correlations of 1 and 2
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X-ray crystal structure of 1
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Key HMBC, 1H-1H COSY, and ROESY correlations of 3 and 4
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Table 1
1H NMR (400MHz) Data of Compounds 1–4 (CDCl3, δ ppm, J in Hz)
1 2 3 4
1 - 6.48, d (7.8) 2.55, ddd (8.2, 7.4, 4.3) 5.50, d (7.8)
2.20, ddd (15.6, 8.2, 7.4)
2 - 6.63, d (7.8) 3.45, d (4.3) 3.45, s
3 - - - -
4 - - - -
5 6.36, s - 5.70, d (12.9) 5.70, d (11.7)
6 - - 2.75, ddd (15.6, 12.9, 8.2) 2.93, dd (11.7, 7.8)
7 - - - -
8 5.61, dd (7.8, 7.8) 5.09, dd (7.0, 7.0) 5.10, dd (7.8, 6.2) 5.43, dd (5.1, 5.1)
9a 2.29, overlapped 2.42, overlapped 2.34, dd (6.6, 6.6) 1.87, dd (5.9, 5.1)
9b 2.24, dd (7.4, 7.4) 2.40, overlapped 2.34, dd (6.6, 6.6) 1.83, dd (5.9, 4.7)
10 5.07, dd (7.4, 1.5) 5.10, dd (7.4, 2.7) 5.05, dd (7.1, 1.5) 2.76, t (5.8)
11 - - - -
12 1.65, s 1.66, s 1.62, s 1.23, s
13 1.52, s 1.57, s 1.68, s 1.26, s
14a 5.30, br s 5.30, br s 5.26, br s 5.40, br s
14b 5.09, br s 5.15, br s 5.12, br s 5.31, br s
15 2.11, s 2.26, s 1.45, s 1.46, s
H-OH 5.47, 5.58, bl s 5.83, 9.00, br s
OAc 2.30, s 2.03, s 2.05, s
OAng
3' 6.08, qq (7.0, 1.5) 6.25, qq (7.0, 1.5) 6.09, qq (7.0, 1.5) 6.11, qq (7.0, 1.5)
3" 6.17, qq (7.4, 1.5)
4' 1.97, dq (7.0, 1.1) 2.05, dq (7.0, 1.5) 1.98, dq (7.0, 1.1) 1.98, dq (7.0, 1.1)
4" 1.98, dq (7.4, 1.5)
5' 1.90, dq (1.5, 1.1) 1.96, dq (1.5, 1.5) 1.89, dq (1.5, 1.1) 1.90, dq (1.5, 1.1)
5" 1.90, dq (1.5, 1.5)
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Table 2
13C NMR (100MHz) Data of Compounds 1–4 (CDCl3, δ ppm)
1 2 3 4
1 129.7 (s) 120.2 (d) 31.8 (t) 71.6 (d)
2 152.1 (s) 121.6 (d) 64.5 (d) 65.6 (d)
3 112.3 (s) 124.0 (s) 61.4 (s) 61.4 (s)
4 146.5 (s) 142.9 (s) 201.5 (s) 199.5 (s)
5 107.9 (d) 140.5 (s) 74.8 (d) 72.8 (d)
6 130.7 (s) 123.2 (s) 43.8 (d) 48.5 (d)
7 144.4 (s) 147.3 (s) 147.5 (s) 145.5 (s)
8 74.8 (d) 76.5 (d) 75.6 (d) 72.6 (d)
9 32.2 (t) 33.2 (t) 32.0 (t) 33.5 (t)
10 119.2 (d) 119.1 (d) 118.9 (d) 60.8 (d)
11 134.1 (s) 134.7 (s) 134.5 (s) 58.3 (s)
12 25.7 (q) 25.7 (q) 25.7 (q) 24.6 (q)
13 17.8 (q) 17.9 (q) 18.0 (q) 18.8 (q)
14 115.0 (t) 114.8 (t) 113.0 (t) 114.8 (t)
15 8.5 (q) 15.4 (q) 14.8 (q) 14.3 (q)
OAc
1' 170.3 (s) 169.7 (s) 169.4 (s)
2' 20.7 (q) 20.2 (q) 20.2 (q)
OAng
1' 167.3 (s) 169.8 (s) 166.8 (s) 166.0 (s)
1" 166.2 (s)
2' 127.9 (s) 127.1 (s) 127.8 (s) 126.6 (s)
2" 127.3 (s)
3' 138.1 (d) 140.9 (d) 138.6 (d) 139.6 (d)
3" 140.9 (d)
4' 15.6 (q) 15.9 (q) 15.7 (q) 15.8 (q)
4" 15.9 (q)
5' 20.6 (q) 20.3 (q) 20.5 (q) 20.5 (q)
5" 20.4 (q)
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Table 3
Cytotoxicity Data of Compounds 1–7 (EC50 µg/mL)
Compound
Cell Line
A549 MCF-7 KB KBVIN
1 3.4 0.8 1.0 0.9
2 >20 10.8 11.8 15.9
3 11.4 7.7 10.4 7.6
4 >20 >20 >20 18.9
5 >20 >20 >20 11.4
6 >20 >20 >20 >20
7 >20 >20 >20 >20
Etoposide 0.4 16.4 3.9 8.8
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